Am. J. Respir. Crit. Care Med., Volume 163, Number 1, January 2001, 12-18

Are Asthma Medications and Management Related to Deaths from Asthma?

MICHAEL J. ABRAMSON, MICHAEL J. BAILEY, FIONA J. COUPER, JAN S. DRIVER, OLAF H. DRUMMER, ANDREW B. FORBES, JOHN J. MCNEIL, E. HAYDN WALTERS, and the Victorian Asthma Mortality Study Group

Departments of Respiratory, Forensic, and Epidemiology and Preventive Medicine, and Victorian Institute of Forensic Medicine, Monash University, Southbank, and Monash Medical School, The Alfred Hospital, Melbourne, Australia

There is controversy about the role of -agonists in asthma mortality, and the impact of asthma management plans remains unclear. We compared blood -agonist levels in patients dying from asthma with those in controls, and estimated the risks associated with specific classes of medication and patterns of management. We identified 89 asthma deaths and recruited 322 patients presenting to hospitals with acute asthma. A questionnaire was administered to the next of kin in 51 cases, and to 202 controls. Blood drawn from 35 cases and 229 controls was assayed for salbutamol. Smoking, drinking, and family problems were significantly more likely among the cases of asthma death than among the controls. The two groups were reasonably well matched with regard to markers of chronic asthma severity. Cases of asthma death were significantly less likely than controls to use a peak flow meter. Written action plans were associated with a 70% reduction in the risk of death. Use of nebulized bronchodilators or oral steroids was significantly more likely in cases of asthma death. Mean blood salbutamol concentrations were 2.5 times higher in cases of asthma. The use of oral steroids for an attack of asthma reduced the risk of death by 90%. More widespread adoption of written asthma management plans, with less reliance on -agonists and closer medical supervision, should reduce asthma mortality.

This article has been cited by other articles:

				A. L. James, F. H. Green, M. J. Abramson, T. R. Bai, M. Dolhnikoff, T. Mauad, K. O. McKay, and J. G. Elliot Airway basement membrane perimeter distensibility and airway smooth muscle area in asthma J Appl Physiol, June 1, 2008; 104(6): 1703 - 1708. [Abstract] [Full Text] [PDF]

				A. L. James and S. Wenzel Clinical relevance of airway remodelling in airway diseases Eur. Respir. J., July 1, 2007; 30(1): 134 - 155. [Abstract] [Full Text] [PDF]

				R. A. Mularski, S. M. Asch, W. H. Shrank, E. A. Kerr, C. M. Setodji, J. L. Adams, J. Keesey, and E. A. McGlynn The Quality of Obstructive Lung Disease Care for Adults in the United States as Measured by Adherence to Recommended Processes Chest, December 1, 2006; 130(6): 1844 - 1850. [Abstract] [Full Text] [PDF]

				M. K. Miller, J. H. Lee, P. D. Blanc, D. J. Pasta, S. Gujrathi, H. Barron, S. E. Wenzel, S. T. Weiss, and for the TENOR Study Group TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma Eur. Respir. J., December 1, 2006; 28(6): 1145 - 1155. [Abstract] [Full Text] [PDF]

				B. T. Ameredes and W. J. Calhoun (R)-Albuterol for Asthma: Pro [a.k.a. (S)-Albuterol for Asthma: Con]. Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 965 - 969. [Full Text] [PDF]

				L van der Merwe, A de Klerk, M Kidd, P G Bardin, and E M van Schalkwyk Case-control study of severe life threatening asthma (SLTA) in a developing community Thorax, September 1, 2006; 61(9): 756 - 760. [Abstract] [Full Text] [PDF]

				A. L. James, J. G. Elliot, M. J. Abramson, and E. H. Walters Time to death, airway wall inflammation and remodelling in fatal asthma Eur. Respir. J., September 1, 2005; 26(3): 429 - 434. [Abstract] [Full Text] [PDF]

				E. T. Naureckas, V. Dukic, X. Bao, and P. Rathouz Short-Acting {beta}-Agonist Prescription Fills as a Marker for Asthma Morbidity Chest, August 1, 2005; 128(2): 602 - 608. [Abstract] [Full Text] [PDF]

				G. J. Rodrigo, C. Rodrigo, and J. B. Hall Acute Asthma in Adults: A Review Chest, March 1, 2004; 125(3): 1081 - 1102. [Abstract] [Full Text] [PDF]

				L. L. Wolfenden, G. B. Diette, J. A. Krishnan, E. A. Skinner, D. M. Steinwachs, and A. W. Wu Lower Physician Estimate of Underlying Asthma Severity Leads to Undertreatment Arch Intern Med, January 27, 2003; 163(2): 231 - 236. [Abstract] [Full Text] [PDF]

				P Phipps and C S Garrard The pulmonary physician in critical care * 12: Acute severe asthma in the intensive care unit Thorax, January 1, 2003; 58(1): 81 - 88. [Abstract] [Full Text] [PDF]

				J. Douglass, R. Aroni, D. Goeman, K. Stewart, S. Sawyer, F. Thien, and M. Abramson A qualitative study of action plans for asthma BMJ, April 27, 2002; 324(7344): 1003 - 1003. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF]

				J C Kips and R A Pauwels Low dose inhaled corticosteroids and the prevention of death from asthma Thorax, September 1, 2001; 56(90002): ii74 - 78. [Full Text] [PDF]

				M. D. Eisner, M. Abramson, M. Bailey, F. Couper, J. Driver, O. Drummer, A. Forbes, J. McNeil, E. H. Walters, and t. Victorian Asthma Mortality Study Group INHALED BETA AGONISTS AND DEATH FROM ASTHMA: REVISITING THE CONTROVERSY Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1502 - 1502. [Full Text]

				R. Beasley and J. Crane Reducing Asthma Mortality with the Asthma Self-Management Plan System of Care Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 3 - 4. [Full Text]